Mylan Inc (MYL) 48.78 $MYL Generic Drugmakers Block

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mylan Inc (MYL) 48.78 $MYL

Generic Drugmakers Block Suitors, but Is That Good or Bad News?
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 15, 6:20AM CST
Image source: Flickr user stockmonkeys.com. In May, I discussed the ongoing war of words being exchanged between generic drugmakers that were the subject of potential megamergers and concluded that Mylan N.V.  wouldn't be likely to sweeten the...
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58), TEVA: 58.01 (-0.32)

Mylan Bid For Perrigo Fails On Shareholder Vote
at Investor's Business Daily - Fri Nov 13, 3:41PM CST
Shareholders of Perrigo (PRGO) rejected a hostile takeover bid by fellow generic drug maker Mylan (MYL) Friday morning, sending Perrigo stock down and Mylan up. Mylan said in a press release that by the 8 a.m. ET deadline some 40% of Perrigo shares...
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58)

JC Penney and Mylan are big market movers
AP - Fri Nov 13, 3:24PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FOSL: 32.39 (-18.62), TYC: 35.31 (-1.19), AMAT: 17.24 (+0.71), LOCO: 10.20 (-1.32), MYL: 48.78 (+5.58), JWN: 53.96 (-9.51), CSCO: 26.21 (-1.62)

Perrigo Shareholders Give Thumbs Down to $34 Billion Mylan Offer
at The Street - Fri Nov 13, 2:44PM CST
Both companies are expected to seek out other M&A opportunities, following the failed buyout bid.
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58), TEVA: 58.01 (-0.32)

Big deal momentum may carry into 2016 for health care
By TOM MURPHY - AP - Fri Nov 13, 1:16PM CST
With $2 trillion in buyouts since January, 2015 has become the year of the megadeal, fueled by free money in a zero-interest rate environment.
CI: 131.57 (+0.18), ANTM: 132.55 (-0.88), PFE: 33.27 (-0.12), ANTX: 44.63 (-0.45), MYL: 48.78 (+5.58)

Stocks Are On Track to Snap Six-Week Winning Streak
at The Street - Fri Nov 13, 11:50AM CST
Stocks move lower on Friday, on track to snap a six-week winning streak, as debate over whether the Federal Reserve might hike rates in December continues.
FOSL: 32.39 (-18.62), PRGO: 146.90 (-9.65), AMAT: 17.24 (+0.71), JCP: 7.44 (-1.35), MYL: 48.78 (+5.58), CSCO: 26.21 (-1.62), YUM: 69.47 (+2.35)

Mylan N.V.'s Hostile Takeover Attempt of Perrigo Fails -- Investors Cheer
Brian Feroldi, The Motley Fool - Motley Fool - Fri Nov 13, 11:34AM CST
What: Shares of Mylan N.V. , a leading manufacturer of generic drugs, were up more than 13% in early morning trading today after news was released that its most recent attempt to takeover fellow drugmaker  Perrigo  has failed. Perrigo's investors...
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58)

Major Averages Take More Heat; Retail Stocks Slammed On Weak Data
at Investor's Business Daily - Fri Nov 13, 10:44AM CST
A sell-off in retail stocks weighed on the major averages near midday Friday after October retail sales data missed expectations. Another big drop in oil prices didn't help matters. The Dow Jones industrial average and Nasdaq each lost 0.8%. The S&P...
RH: 92.57 (-6.52), PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58), ULTA: 155.20 (-14.16), PLNT: 16.07 (+1.04), SIG: 136.42 (-4.72), PAYC: 41.04 (-3.31)

Stocks Drop as Fed's Mester Says Time for Rate Hike 'Quickly Approaching'
at The Street - Fri Nov 13, 10:19AM CST
Stocks move lower on Friday after Cleveland Fed President Loretta Mester says the time for a rate hike is nearing.
FOSL: 32.39 (-18.62), PRGO: 146.90 (-9.65), AMAT: 17.24 (+0.71), JCP: 7.44 (-1.35), JWN: 53.96 (-9.51), MYL: 48.78 (+5.58), CSCO: 26.21 (-1.62), YUM: 69.47 (+2.35)

Stocks Falter At Start Of Trade; Fossil, El Pollo, GameStop Slide
at Investor's Business Daily - Fri Nov 13, 9:34AM CST
Stocks again opened to narrow losses on Friday, with retail sector stocks experiencing unusually heavy selling. The Nasdaq hurt worst, down 0.9%. The Dow Jones industrial average carved out a 0.7% decline and the S&P 500 fell 0.5%. Trade was mixed,...
FOSL: 32.39 (-18.62), PRGO: 146.90 (-9.65), MON: 93.78 (+0.90), SYT: 74.78 (+5.63), GME: 37.18 (-7.35), AMAT: 17.24 (+0.71), LOCO: 10.20 (-1.32), JWN: 53.96 (-9.51), MYL: 48.78 (+5.58), XRS: 40.71 (-0.19), PAYC: 41.04 (-3.31)


Perrigo to go it alone; shareholders reject $26B Mylan bid
By TOM MURPHY - AP - Fri Nov 13, 9:33AM CST
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
MYL: 48.78 (+5.58)

Mylan (MYL) Stock Soars, Loses $26 Billion Hostile Bid for Perrigo
at The Street - Fri Nov 13, 8:19AM CST
Mylan (MYL) stock is spiking in pre-market trading on Friday, after its hostile bid for Perrigo (PRG) failed as only 40% of Perrigo shareholders backed of the deal.
MYL: 48.78 (+5.58)

Stock Futures Dig Deeper; Perrigo, Nordstrom, Cisco Tumble
at Investor's Business Daily - Fri Nov 13, 8:05AM CST
Stock futures shook another leg down before Friday's open after disappointing readings on retail sales and producer prices. Dow futures shed 53 points, down from a 31-point loss an hour earlier. Nasdaq 100 futures were down 18.7 points and falling....
FIT: 27.86 (-3.82), PSX: 89.08 (-0.16), PRGO: 146.90 (-9.65), NTES: 148.11 (-5.23), MON: 93.78 (+0.90), GME: 37.18 (-7.35), MYL: 48.78 (+5.58), FOSL: 32.39 (-18.62), SYT: 74.78 (+5.63), JCP: 7.44 (-1.35), LOCO: 10.20 (-1.32), JWN: 53.96 (-9.51), ROST: 44.81 (-3.30), CSCO: 26.21 (-1.62), BHI: 47.66 (-0.48)

Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer
PR Newswire - Fri Nov 13, 7:39AM CST
Mylan N.V. (NASDAQ: MYL; TASE) today announced that its offer to acquire all of the issued and to be issued share capital of Perrigo Company plc (NYSE: PRGO; TASE) has lapsed.
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58)

Stock Futures Fall as Producer Prices, Retail Sales Disappoint
at The Street - Fri Nov 13, 7:38AM CST
Stock futures extend Thursday's selloff into Friday's session after retail sales come in far weaker than expected and producer prices unexpectedly decline.
PRGO: 146.90 (-9.65), FOSL: 32.39 (-18.62), AMAT: 17.24 (+0.71), JCP: 7.44 (-1.35), MYL: 48.78 (+5.58), LOCO: 10.20 (-1.32), JWN: 53.96 (-9.51), CSCO: 26.21 (-1.62), YUM: 69.47 (+2.35)

Nov. 13 Premarket Briefing: 10 Things You Should Know
at The Street - Fri Nov 13, 5:53AM CST
U.S. stock futures are slightly lower ahead of data on retail sales and consumer sentiment.
TYC: 35.31 (-1.19), PRGO: 146.90 (-9.65), MON: 93.78 (+0.90), MYL: 48.78 (+5.58), DIS: 114.84 (-1.37), TWX: 69.93 (-0.49), NFLX: 103.65 (-5.27), SYT: 74.78 (+5.63), JCP: 7.44 (-1.35), FOXA: 29.69 (-0.33), CMCSA: 60.23 (-1.26), CSCO: 26.21 (-1.62), YUM: 69.47 (+2.35)

Mylan, Perrigo bicker over bid
at Investor's Business Daily - Thu Nov 12, 5:45PM CST
Perrigo (PRGO) shareholders vote Fri. on Mylan's hostile takeover offer, with many saying the outcome is too close to call. Mylan (MYL) says its bid of $75 plus 2.3 Mylan shares per Perrigo share tops Perrigo's "average hypothetical unaffected" price...
PRGO: 146.90 (-9.65), MYL: 48.78 (+5.58)

Mylan Falls 2.90% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 12, 5:13PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $42.56 to a high of $44.73. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $44.28 on volume of 12.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 48.78 (+5.58)

Mylan Set to Possibly Rebound After Yesterday's Selloff of 2.90%
Comtex SmarTrend(R) - Thu Nov 12, 5:11PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $42.56 to a high of $44.73. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $44.28 on volume of 12.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 48.78 (+5.58)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Zadarma Unveils Innovative Multilingual AI Voice Assistant

Updated Category News Views 106

Introducing the Zadarma AI Voice Agent Zadarma, recognized for its exceptional VoIP services, has introduced an innovative virtual assistant - the Zadarma AI Voice Agent. This cutting-edge tool is designed to revolutionize customer interactions by providing seamless call handling, whether during traditional business hours or after hours. 24/7 Customer Support The Zadarma...

Continue Reading
Exploring Shift4 Payments Inc.'s P/E Ratio Trends and Insights

Updated Category News Views 199

Analyzing Shift4 Payments Inc. Stock Performance Shift4 Payments Inc. (NYSE: FOUR) is currently valued at $93.44, reflecting a decrease of 1.22% in today’s trading session. Despite this minor drop, there is good news: over the last month, the stock has climbed by 7.41%, and impressively, it has surged by 102.95% within the past year. This rapid appreciation has led many...

Continue Reading
SkyWest Insider Sells $2.01 Million Worth of Shares

Updated Category News Views 97

Wade J Steel Executes Major Sell Order of SkyWest Stock A significant insider transaction has come to light with Wade J Steel, Chief Commercial Officer at SkyWest (NASDAQ: SKYW), recently selling shares of the company worth $2.01 million. This transaction was documented through the latest SEC filing. Understanding the Sale The SEC filing revealed that Steel sold a total...

Continue Reading
Marpai Inc. to Discuss 2024 Financial Results in Upcoming Webcast

Updated Category News Views 140

Marpai Inc. Announces Webcast for Financial Results Marpai, Inc. is set to hold a conference call and webcast aimed at presenting vital operational and financial details surrounding its results for 2024. They are a leading technology platform company, operating as a respected Third-Party Administrator (TPA) within the health insurance sector. Marpai actively works to...

Continue Reading
Marex Group Investors Urged to Act Ahead of Critical Deadline

Updated Category News Views 160

Understanding the Legal Landscape for Marex Group Investors As an investor in Marex Group plc (NASDAQ: MRX), it's essential to stay informed and proactive regarding upcoming legal proceedings that may affect your investments. The Rosen Law Firm, a global leader in investor rights, has announced an important deadline for shareholders who purchased securities during a...

Continue Reading